Omnicell appoints Nnamdi Njoku as President; Lipps remains CEO and Chairman

OMNICELL, INC.

Nnamdi Njoku appointed President of Omnicell effective July 1, 2026, while retaining COO role.
Randall Lipps steps down as President but continues as CEO and Chairman of the Board; no compensation change.
Njoku receives one-time RSU award of ~$500k vesting over three years; base salary unchanged at $661k, target bonus 100%.
Njoku to lead growth strategy, launch of Titan XT automated dispensing system and OmniSphere platform.
Njoku previously served as EVP and COO since Oct 2024; prior roles at Medtronic, Zimmer Biomet.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.